Clinical Trials Market OverviewThe Clinical Trials Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Health care jobs are among the best-paying because, experts say, the high cost of education and training often involves years ...

Q4 2024 Earnings Call Transcript February 12, 2025 Operator: Good morning. My name is Jennifer and I will be your conference ...

Health system CFOs discuss trends and strategies for navigating the complex financial landscape of 2025, from Medicare Advantage to AI and private equity.

The company focuses on liver cancer treatments, with its leading product HEPZATO KIT and ongoing FOCUS clinical trial for metastatic uveal ... while MorningStar considers the stock 50% overvalued. The ...

Physician enablement company Privia Health (Nasdaq: PRVA) saw its 10 ACOs achieved aggregate shared savings of $176.6 million ...

"I worked in the army hospital on Ft. Lewis. A woman came in for belly pain, and we found out and told her she was 10 weeks ...

The first of Opthea’s (ASX:OPT) two phase III eye disease trials has hit a key development milestone, with the last patient ...